Acteos SA (EOS) AI Stock Analysis

Acteos SA

(Paris:EOS)

Select Model

Rating:39Underperform

Price Target:EUR 0.72▼(-1.64% Downside)

Action:reiterated

Date:08/06/26

Acteos SA receives a profoundly constrained score driven primarily by a highly distressed financial profile that includes chronic net losses, falling revenues, and severe solvency risks. Unfavorable valuation metrics and long-term bearish technical trends further restrict the stock's overall appeal.

Positive Factors

Operating Profitability TurnaroundThe sharp improvement in operating profitability indicates that Acteos can generate stronger earnings from its core activities despite lower revenue. If sustained, this turnaround could improve internal funding capacity, support product investment, and strengthen resilience over the next several quarters.

Negative Factors

Multi-Year Revenue ContractionPersistent revenue contraction is a fundamental weakness because it limits the scale of Acteos’s software platform and reduces the base over which fixed development and operating costs can be spread. Continued declines could undermine the recent operating improvement and constrain future investment.

Acteos SA (EOS) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 2.54M
Dividend Yield: ―
Average Volume (3M): 478
Price to Earnings (P/E): -4.0
Beta (1Y): 0.15
Revenue Growth: -13.79%
EPS Growth: 91.69%
Country: France
Employees: 47
Sector: Services
Sector Strength: 55
Industry: Software - Application

Acteos SA Business Overview & Revenue Model

Company Description

Acteos SA designs, develops, integrates, and provides software and related services in the field of supply chain management mobile solutions in France, Germany, and Lebanon. It offers Acteos, a supply chain software; transportation management system...

How the Company Makes Money

Acteos primarily makes money by commercializing its supply-chain software products and related services. Key revenue streams typically include: (1) software licensing and/or subscription fees for the use of its applications (pricing generally tied to...

Acteos SA Financial Statement Overview

Summary

Acteos faces significant headwinds with declining revenues, persistent net losses, negative free cash flow, and severe solvency risks highlighted by a substantial stockholders' equity deficit, despite improved gross margins and debt reduction.

Income Statement

30Negative

Balance Sheet

15Very Negative

Cash Flow

35Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	8.44M	8.44M	13.04M	14.54M	19.46M	12.96M
Gross Profit	5.55M	5.55M	8.09M	8.50M	-72.61K	-782.77K
EBITDA	685.54K	730.42K	872.13K	1.23M	1.23M	642.19K
Net Income	-629.49K	-629.00K	-1.25M	-134.06K	-167.11K	-735.42K
Balance Sheet
Total Assets	10.04M	10.04M	10.03M	14.99M	15.71M	15.98M
Cash, Cash Equivalents and Short-Term Investments	1.72M	1.72M	1.54M	1.14M	3.62M	4.08M
Total Debt	3.65M	3.65M	3.92M	3.93M	5.64M	7.01M
Total Liabilities	12.59M	12.59M	11.96M	15.51M	16.06M	16.18M
Stockholders Equity	-2.54M	-2.54M	-1.93M	-520.68K	-355.81K	-201.33K
Cash Flow
Free Cash Flow	-189.59K	-189.59K	1.02M	-2.73M	1.03M	1.46M
Operating Cash Flow	1.05M	1.05M	1.26M	-653.62K	2.11M	2.28M
Investing Cash Flow	-542.70K	-542.70K	-895.44K	-7,807	-1.14M	-796.02K
Financing Cash Flow	-313.89K	-313.89K	-1,127	-1.80M	-1.42M	-2.16M

Acteos SA Technical Analysis

Technical Analysis SentimentNegative

Last Price0.73

Price Trends

50DMA0.82Negative

100DMA0.83Negative

200DMA0.87Negative

Market Momentum

MACD-0.01Positive

RSI33.14Neutral

STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EOS, the sentiment is Negative. The current price of 0.73 is below the 20-day moving average (MA) of 0.79, below the 50-day MA of 0.82, and below the 200-day MA of 0.87, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 33.14 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:EOS.

Acteos SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

FR:EOS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:DSY	81Outperform	EUR 33.82B	25.01	14.48%	1.07%	-0.17%	13.88%
FR:SWP	76Outperform	EUR 322.47M	14.96	29.87%	5.92%	8.08%	4.16%
FR:ALBFR	75Outperform	EUR 299.07M	31.89	18.29%	―	12.55%	13.10%
FR:QDT	61Neutral	EUR 489.38M	-7.22	-8.25%	5.19%	-10.15%	-227.21%
Sector *	55Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%
FR:PROAC	44Neutral	EUR 8.13M	-6.00	1179.01%	―	―	―
FR:EOS	39Underperform	EUR 2.54M	-3.97	4.28%	―	-13.79%	91.69%

* Services Sector Average

Performance Comparison

FR:EOS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:EOS	Acteos SA	0.76	-0.25	-25.12%
FR:DSY	Dassault Systemes (UK)	25.26	1.54	6.49%
FR:PROAC	Proactis SA	0.06	0.02	36.36%
FR:QDT	Quadient Sa	14.44	0.70	5.08%
FR:SWP	SWORD GROUP SE	33.80	-0.25	-0.74%
FR:ALBFR	Sidetrade SA	209.50	-15.50	-6.89%

Acteos SA Corporate Events

Acteos Returns to Operating Profit as SaaS Push Lifts Margins in H1 2026

Oct 28, 2026

Acteos reported first-half 2026 revenue broadly stable at €4.1 million, driven by a 16.6% increase in its core SCM software activities, which now account for about 75% of group sales. SaaS revenues rose to 25% of recurring software income, refl...

Acteos Delays Publication of First-Half 2026 Financial Results

Sep 10, 2026

Acteos SA has announced a postponement of its publication of financial results for the first half of 2026, which was originally scheduled for 10 September after market close. The company now plans to release these interim figures no later than 28 Oct...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 06, 2026

Acteos SA AI Stock Analysis